Home>Topics>Stocks>EnteroMedics

EnteroMedics ETRM

  1. All
  2. Commentary
  3. Headlines

    Related Topics:

    1. Vagal blocking therapy feasibility study results

      Headlines

      Thu, 28 Aug 2014

      Harvard Medical School's Dr. Scott Shikora presents data from EnteroMedics ' ( ETRM +5.1% ) 28-patient DM2 ENABLE study assessing the feasibility of VBLOC vagal block therapy delivered via its Maestro RC System

    2. Premarket Gainers / Losers

      Headlines

      Thu, 28 Aug 2014

      Gainers: SGOC +30.4% . DGLY +21.67% . CREG +20.14% . RPRX +16.42% . ETRM +13.87% . LAS +13.23% . SCOK +10.71% . COBR +9.57% . TKMR +8.61% . SIG +5.65% . Losers: GOMO -20.19

    3. Medtech Shifts From High Gear Into Overdrive: Canaccord's William Plovanic

      Headlines

      Wed, 20 Aug 2014

      By Life Sciences Report : Rapid growth in the medical device industry and changes in the regulatory environment have propelled valuations in the medtech sector to the high end of the range. But new technologies create new investment opportunities. In this interview with The Life Sciences Report ,

    4. EnteroMedics shares jump as FDA panel supports obesity device

      Headlines

      Wed, 18 Jun 2014

      June 18 (Reuters) - EnteroMedics Inc's shares jumped about 37 percent in premarket trading on Wednesday, a day after an advisory panel to the U.S. Food and Drug Administration voted in favor of the...

    5. Dropping Coverage of EnteroMedics

      Commentary

      Fri, 5 Jul 2013

      We are no longer providing equity research on EnteroMedics ETRM . We provide broad coverage of more than 1,700 companies across more than 140 industries and adjust our coverage as necessary based on client demand and investor interest.

    6. EnteroMedics Moves Closer to Unblinding Its Pivotal Study for Maestro

      Commentary

      Wed, 24 Oct 2012

      EnteroMedics ETRM posted third-quarter results that ..... value estimate unchanged. Although EnteroMedics has begun to roll out its Maestro system ..... until after 2017. In the meantime, EnteroMedics burned through another $5.6 million

    7. EnteroMedics Enters the Home Stretch With Maestro

      Commentary

      Tue, 7 Aug 2012

      EntroMedics ETRM has made significant progress ..... valuation shortly. Now that EnteroMedics has shored up its cash ..... full year 2012. While EnteroMedics began its launch in Kuwait ..... 2013, especially after EnteroMedics has submitted its last

    8. After Stabilizing its Finances, EnteroMedics Looks Forward to Commercializing Maestro

      Commentary

      Tue, 24 Apr 2012

      Now that EnteroMedics ETRM has made significant progress on ..... Australia. For the first time, EnteroMedics booked product revenue, following ..... distributor. Perhaps most important, EnteroMedics has put financing in place to keep

    9. EnteroMedics' Shares Rise on Optimism about Orexigen's Diet Drug

      Commentary

      Wed, 8 Dec 2010

      EnteroMedics ETRM saw its shares run up substantially ..... outcome has breathed some hope into EnteroMedics ' stock. However, this is not enough ..... to raise our fair value estimate for EnteroMedics at this time. Nonetheless, we are

    10. EntroMedics Sees Slight Glimmer

      Commentary

      Tue, 22 Jun 2010

      EnteroMedics ETRM shared favorable data on its obesity ..... fourth quarter, which is when we expect EnteroMedics will run out of cash. We're not ..... what happened several years ago, when EnteroMedics reported impressive weight loss results

    « Prev12Next »
    Content Partners